Where is NeuroSync located?

NeuroSync is headquartered in Holliston, United States.

Who is the current CEO of NeuroSync?

Gary Gregory of NeuroSync. They have also founded 1 company.

How many employees does NeuroSync have?

As of Sep 30, 2026, the latest employee count at NeuroSync is 36.

Is NeuroSync a funded company?

NeuroSync is a funded company, having raised a total of $7.43M across 3 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Apr 04, 2017.

When was the latest funding round of NeuroSync?

NeuroSync's latest funding was a $***** Series A round on Jan 10, 2018, with participation from 1 investor. Its primary sector is Neurology. In United States, the Neurology sector has seen $4.57B in funding in 2026 to date.

Where does NeuroSync rank among its competitors?

NeuroSync ranks 11th amongst 95 active competitors, of which 29 are funded. It stands 8th in terms of total funding among its competitors. The most recent competitor to raise funding was neuroClues, which secured $11.6M in Apr, 2026.

Who are the top competitors of NeuroSync?

NeuroSync's top competitors include Neuralight, neuroClues and NovaSight. Among them, neuroClues secured the most recent funding round in April, 2026.

NeuroSync - 2026 Company Profile, Team, Funding & Competitors

NeuroSync is a series A company based in Holliston (United States), founded by Jamshid Ghajar and Gary Gregory. It operates as a Developer of virtual reality hardware and software for brain diagnostics. NeuroSync has raised $7.43M in funding from Quadrant. The company has 95 active competitors, including 29 funded and 1 that has exited. Its top competitors include companies like Neuralight, neuroClues and NovaSight.

Company Details

Developer of virtual reality hardware and software for brain diagnostics. This technology utilizes eye tracking and artificial intelligence to quantify neurological function. The platform provides objective data to assist in the assessment of brain health and performance. These tools are designed for use in clinical, research, and performance environments to monitor physiological responses and track changes over time.

Website: neurosync.health
Social

Key Metrics

Location

Holliston, United States

Stage

Series A

Total Funding

$7.43M in 3 rounds

Latest Funding Round

Series A, Jan 10, 2018, $*****

Investors

Quadrant & 5 more

Ranked

11^th among 95 active competitors

Employee Count

36 as on Sep 30, 2026

Similar Companies

OpenEvidence & 2993 more

View NeuroSync's full profile

NeuroSync is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Reports
NEUROSYNC INC. CIN: 4554267 , United States, Active	May 29, 2008	-	-	-

NeuroSync has raised a total funding of $7.43M over 3 rounds. Its first funding round was on Apr 04, 2017. Its latest funding round was a Series A round on Jan 10, 2018 for $*****. 1 investor participated in its latest round. NeuroSync has 6 institutional investors.

Here is the list of recent funding rounds of NeuroSync:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jan 10, 2018	3614316	Series A	1155680	3301534	3681433	7031556
Sep 07, 2017	7352229	Seed	5935219	2497698	8267485	3636290
Apr 04, 2017	4413248	Grant (prize money)	5246027	4948085	5928667	MassChallenge

Access funding benchmarks and valuations. Sign up today!

View details of NeuroSync's funding rounds and investors

The founders of NeuroSync are Jamshid Ghajar and Gary Gregory. Gary Gregory is the CEO of NeuroSync.

Here are the details of NeuroSync's key team members:

Jamshid Ghajar: Founder of NeuroSync and founder of 1 other company.
Gary Gregory: Founder & CEO of NeuroSync.
Contact Info: 1 email address

View details of NeuroSync's Founder profiles and Board Members

NeuroSync's employee count trend

NeuroSync has 36 employees as of Sep 26. Here is NeuroSync's employee count trend over the years:

Uncover NeuroSync's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of NeuroSync include Neuralight, neuroClues and NovaSight. Here is the list of Top 10 competitors of NeuroSync, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Neuralight 2021, San Francisco (United States), Series A	AI-based neurological evaluation and assessment tool for diagonosis	$30.5M	Koch Disruptive Technologies, Global Founders Capital ... & 17 others	57/100
2nd	neuroClues 2020, Louvain-la-neuve (Belgium), Series A	Provider of eye-tracking devices for healthcare practitioners	$21.8M	Graph Ventures, Europa & 11 others	54/100
3rd	NovaSight 2016, Lod (Israel), Series B	Provider of eye-tracking-based solutions for vision assessment and treatment	$20M	Rimonci, EIT Health	47/100
4th	Senseye 2015, Austin (United States), Series B	Provider of a smartphone-based mental health diagnostic platform	$17.4M	Oracle, Wavemaker Partners & 5 others	46/100
5th	Neurotrack 2012, Redwood City (United States), Series C	Provider of clinical assessment tool to diagnose neurological disorders	$57.8M	Khosla Ventures, Sozo Ventures & 17 others	47/100
6th	Araya Brain Imaging 2013, Chiyoda City (Japan), Series B	Neuroimaging technology and services	$9.3M	31VENTURES, Sumitomo Shoji Machinex Co.,Ltd. ... & 7 others	44/100
7th	Tobii Dynavox 1983, Danderyd (Sweden), Late Stage	Provider of assistive communication solution for differently abled people via eye-tracking	-	Vestar Capital Partners	44/100
8th	Oculogica 2013, New York City (United States), Series B	Eye tracking technology to detect traumatic brain injury (TBI)	$22M	TitletownTech, Sofia Fund & 8 others	43/100
9th	machineMD 2019, Bern (Switzerland), Seed	Developer of a device for the diagnosis of brain disease	$4.77M	Guido Fluri Stiftung, MassChallenge & 3 others	42/100
10th	C. Light Technologies 2014, Berkeley (United States), Seed	Developer of eye-tracking solution provider to detect and monitor neurodegenerative diseases	$3.25M	Creative Ventures, Alzheimer's Drug Discovery ... & 10 others	42/100
11th	NeuroSync Holliston (United States), Series A	Developer of virtual reality hardware and software for brain diagnostics	$7.43M	Oceanic Partners, MassChallenge & 4 others	42/100